ÈÕ±¾¶«¾©ºÍÃÀ¹úÂíÈøÖîÈûÖݽ£ÇÅÊУ¬2021Äê11ÔÂ11ÈÕ-ng28ÄϹ¬Öêʽ»áÉ磨×ܲ¿£º¶«¾©£¬CEO£ºÄÚÌÙÇç·ò£¬ÒÔϼò³Æ¡°ng28ÄϹ¬¡±£©ºÍ²³½¡¹«Ë¾£¨Nasdaq£ºBIIB£¬¹«Ë¾×ܲ¿£ºÂíÈøÖîÈûÖݽ£ÇÅÊУ¬CEO£ºMichel Vounatsos£¬ÒÔϼò³Æ¡°²³½¡¡±£©½üÈÕÐû²¼ÁËLecanemab IIbÆÚ£¨201£©ºÍ¿ª·ÅÑÓÕ¹ÊÔÑ飨OLE£©Ñо¿ÖйØÓÚÄÔµí·ÛÑùÂѰ׼õÉÙºÍÔçÆÚ°¢¶û´Äº£Ä¬²¡£¨AD£©»¼ÕßµÄÎåÄêÁÙ´²×´Ì¬µÄÐÂÁÙ´²¡¢ÉúÎï±ê¼ÇÎïºÍÄþ¾²ÐÔÆÀ¹À½á¹û¡£ÔÚ2021Äê11ÔÂ9ÈÕÖÁ12ÈÕÓÚÂíÈøÖîÈûÖݲ¨Ê¿¶Ù¾ÙÐеÄ2021Äê°¢¶û´Äº£Ä¬²¡ÁÙ´²ÊÔÑ飨CTAD£©¼¯»áÉÏ£¬ÔÚ×îеÄÔ²×À¼¯»áÉÏÐû²¼ÁËÕâЩ·¢Ã÷²¢ÓëÁÙ´²Ñо¿ÈËÔ±½øÐÐÁËÌÖÂÛ¡£½üÈÕ£¬ng28ÄϹ¬×î½ü¿ªÊ¼Æ¾¾Ý¼ÓËÙÅú׼ͨµÀÏòÃÀ¹úʳƷҩƷ¼à¶½ÖÎÀí¾Ö£¨FDA£©×ª¶¯Ìá½»Lecanemab£¨Ò»ÖÖÊÔÑéÐÔ¿¹µí·ÛÑùÂѰצ [A¦Â]ÔÏËά¿¹Ì壩ÓÃÓÚÖÎÁÆÔçÆÚADµÄÉúÎïÖÆÆ·Ðí¿ÉÉêÇ루BLA£©¡£
OLEÑо¿Ì½Ë÷ÎåÄêÄÚµÄÉúÎï±ê¼ÇÎïºÍÁÙ´²ÁÆÐ§
ÔÚ¶ÔΪÆÚ18¸öÔµĽ¹µã½×¶Î£¨201Ñо¿£¬Alz Res Therapy 13;21£©½øÐÐÆÊÎöºó£¬¿ªÕ¹ÁË10 mg/kg Lecanemab¸øÒ© £¨¾²Âö×¢É䣬ÿÁ½ÖÜÒ»´Î£©µÄOLEÑо¿£¬ÖмäµÄÐÝÒ©ÆÚ£¨¼ä¸ôÆÚ£©¹æÄ£Îª9-59¸öÔ£¨Æ½¾ù24¸öÔ£©¡£OLE½×¶ÎÆÀ¹ÀÁËLecanemabÔÚ12¸öÔÂÖÎÁÆÆÚ¼ä¶Ôµí·ÛÑùÂѰ×Õýµç×Ó·¢Éä¶Ï²ã³ÉÏñ£¨PET£©µÄÓ°Ïì¡£±¾Ñо¿Éè¼ÆÎªÌ½Ë÷ÔÚ5ÄêµÄ¼²²¡¹ì¼£ÖÐÍ£ÓúÍÖØÐ¿ªÊ¼LecanemabÖÎÁƵÄÉúÎï±ê¼ÇÎïºÍÁÙ´²ÁÆÐ§ÌṩÁËʱ»ú¡£µí·ÛÑùÂѰ׼õÉÙÓëÁÙ´²»ñÒæÏà¹Ø
OLE½×¶ÎµÄ¸üÐÂÆÀ¹ÀÏÔʾ£¬»ùÓÚOLEÊý¾ÝºÍµí·ÛÑù°ß¿éµÄÎȽ¡Çå³ýÂÊ£¬½ÓÄÉLecanemabÖÎÁÆ¿ÉÔÚ3¸öÔÂÄÚ½µµÍÄÔµí·ÛÑùÂѰ×ˮƽ£¬ÇÒ¾PETÕÉÁ¿£¨Ä¿ÊÓ¶ÁÊý£©£¬Áè¼Ý80%µÄÊÜÊÔÕߣ¨10/12£©ÔÚ½ÓÊÜÖÎÁÆ12-18¸öÔºóµÖ´ïµí·ÛÑùÂѰ×ÒõÐÔ״̬¡£ÕâЩ½á¹ûÓë½¹µã½×¶Î½á¹ûÒ»Ö¡£201Ñо¿½¹µã½×¶ÎÊý¾Ý±êÃ÷£¬ÔÚȺÌ壨Ïà¹ØÏµÊý=0.832£¬pÖµ=0.080£©ºÍÊÜÊÔÕßˮƽ£¨Ïà¹ØÏµÊý=0.201£¬Ð±ÂÊ=0.199£¬p=0.036£©Ï£¬ÁÙ´²ÓÐЧÐÔ£¨ADCOMS£©Óëµí·ÛÑùÂѰ׽µµÍ£¨PET SUVr£©Ïà¹Ø¡£¾¶¨Á¿ÆÀ¹À£¬ÔÚÖÎÁÆ¿ªÊ¼ºó3¸öÔ£¬Ê״νÓÊÜÖÎÁƵÄOLEÊÜÊÔÕߵĵí·ÛÑùPETˮƽÏÔÖø½µµÍ¡£±ðµÄ£¬½¹µã½×¶ÎÊý¾Ý±êÃ÷£¬ÔÚȺÌ壨Ïà¹ØÏµÊý=-0.306£¬²»ÏÔÖø£©ºÍÊÜÊÔÕßˮƽ£¨Ïà¹ØÏµÊý=-0.208£¬Ð±ÂÊ=-3.957£¬pÖµ=0.050£©Ï£¬ÁÙ´²ÓÐЧÐÔÓëѪ½¬A¦ÂÏà¹Ø¡£
ÈÏÖª¹¦Ð§Ï½µµÄDZÔÚ¼õ»º¿ÉÄÜÌáʾ¼²²¡ÐÞÊÎ×÷ÓÃ
½¹µã½×¶Î½áÊøÊ±£¬ÔÚ24¸öÔµÄÐÝÒ©ÆÚÄÚÖÕÖ¹¸øÒ©ºó£¬LecanemabÖÎÁÆ×éºÍο½å¼Á×éÖ®¼äÑо¿¼ÓÈëÕßµÄÁÙ´²ÖÎÁƲî±ðµÃÒÔά³Ö¡£ÔÚΪÆÚ18¸öÔµĽ¹µã½×¶Î½áÊøÊ±£¬Óë½ÓÊÜο½å¼ÁµÄÊÜÊÔÕßÏà±È£¬½ÓÊÜ×î¸ß¼ÁÁ¿LecanemabµÄÊÜÊÔÕßµÄÁÙ´²Ï½µ¼õÉÙ±êÃ÷ADCOMS²î±ðΪ0.05£¨Î¿½å¼Á×éΪ0.19£¬Lecanemab×éΪ0.14£©¡£ÔÚÈë×éOLEÑо¿µÄÊÜÊÔÕßÖУ¬¸ÃÖÎÁƲî±ðΪ0.10£¬ÇÒÔÚÖÁOLE¿ªÊ¼µÄÐÝÒ©ÆÚ¼ä¼á³ÖÎȶ¨£¨Î¿½å¼Á×éΪ0.28£¬Lecanemab×éΪ0.18£©¡£ÔÚÁÙ´²³Õ´ôÆÀ¶¨Á¿±í-×Ü·Ö£¨CDR-SB£©ºÍ°¢¶û´Äº£Ä¬²¡ÆÀ¹ÀÁ¿±í-ÈÏÖª·ÖÁ¿±í£¨ADAS-Cog£©ÖÐÊӲ쵽ÏàËÆµÄ½á¹û£¬¾¡¹ÜÁ½×é¾ùÁ¬Ðø½øÕ¹¡£Í£ÓÃLecanemabºó£¬ÉúÎï±ê¼ÇÎïÒÔ¼°µí·ÛÑùÂѰ×PET¡¢Ñª½¬A¦Â42/40ºÍptau181Ëù·´Ó¦µÄÁ¬ÐøÖÎÁÆÐ§¹ûģʽÓë¼²²¡ÐÞÊÎ×÷ÓÃÒ»Ö¡£
ѪҺ¼ì²é¿ÉÄÜ¿ÉÓÃÓÚ¼à²âLecanemabÖÎÁÆÐ§¹û
ÌṩÁËIIbÆÚºÍOLEÑо¿ÖвâµÃµÄÁ½ÏîÐÂѪҺ¼ì²éµÄнá¹û£ºÑª½¬A¦Â42/40±ÈÖµºÍѪ½¬p-tau181¡£Ñª½¬A¦Â42/40±ÈÖµµÄ±ä¸ïÓëµí·ÛÑùÂѰ×PETµÄ±ä¸ï³Ê¸ºÏà¹Ø¡£ÔÚ½¹µã½×¶Î£¬µí·ÛÑùÂѰ×PETºÍѪA¦ÂµÄȺÌåºÍ¸öÌåˮƽ¾ùÓëADCOMSÏà¹Ø£¨PETÏà¹ØÏµÊý=0.832 [ȺÌå]¡¢0.201 [ÊÜÊÔÕßˮƽ]£»A¦ÂѪ½¬Ïà¹ØÏµÊý£º-0.306 [ȺÌå]¡¢-0.208 [ÊÜÊÔÕßˮƽ]£©¡£ÀûÓÃѪ½¬ÉúÎï±ê¼ÇÎï¼à²âÖÎÁÆÐ§¹û¿ÉÄÜÔÊÐíÔÚÎȽ¡È¥³ýµí·ÛÑùÂѰ׺ó½øÐмòµ¥µÄ¼ÁÁ¿µ÷½â£¨ÀýÈ磬½µµÍƵÂʺÍ/»ò¼õÉÙ¼ÁÁ¿£©¡£
½¹µã½×¶ÎºÍOLE½×¶ÎÖеí·ÛÑùÂѰ×Ïà¹ØÓ°ÏñѧÒì³£–Ë®Ö×£¨ARIA-E£©±¬·¢ÂʺÍÖ¢×´ÐÔARIA±¬·¢Âʽϵ͵ÄÄþ¾²ÐÔÌØÕ÷
Óë½¹µã½×¶ÎµÄÄþ¾²ÐÔ½á¹ûÒ»Ö£¬LecanemabÄÍÊÜÐÔÁ¼ºÃ£¬ÇÒ½¹µã½×¶ÎºÍOLE½×¶ÎÖÐ10 mg/kgÿÁ½ÖÜÒ»´Î¼ÁÁ¿×éµÄARIA-E±¬·¢ÂÊ<10%¡£½¹µã½×¶ÎºÍOLE½×¶ÎÖÐÖ¢×´ÐÔARIA-EµÄ±¬·¢ÂÊ<2%¡£¸ÃÄþ¾²ÐÔÌØÕ÷ʹLecanemabÄܹ»ÒÔÖÎÁƼÁÁ¿¿ªÊ¼¸øÒ©£¬ÎÞÐèµÎ¶¨¡£
ng28ÄϹ¬Éñ¾²¡Ñ§ÒµÎñ×éÊ×ϯҽÁƹÙLynn Kramerҽѧ²©Ê¿ÌåÏÖ£º¡°×îеÄLecanemab·¢Ã÷Ϊ½ÓÄÉLecanemabÖÎÁÆÊ±ÊӲ쵽µÄµí·ÛÑùÂѰ׼õÉÙµÄʱ³ÌºÍˮƽÒÔ¼°ÆäÓëÁÙ´²½á¾ÖºÍѪҺÉúÎï±ê¼ÇÎïµÄ¹ØÏµÌṩÁ˸üÉîÈëµÄÀí½â¡±¡£¡°3Ô·ÝÍê³É1795ÀýÊÜÊÔÕßÈë×éµÄÔçÆÚAD IIIÆÚÑо¿£¨Clarity AD£©Ö¼ÔÚÑéÖ¤ÕâЩ·¢Ã÷¡±¡£
¿ÉÓÚ11ÔÂ11ÈÕÃÀ¹ú¶«²¿±ê׼ʱ¼äÍíÉÏ10:00£¬ÔÚng28ÄϹ¬Öêʽ»áÉçÍøÕ¾ÉϵÄͶ×ÊÕßÕ½ڻñÈ¡ÑÝʾÊÓÆµºÍ»ÃµÆÆ¬¡£
±¾ÎÄÌÖÂÛÁËÒ©ÎïÔÚ¿ª·¢ÖеÄÊÔÑéÐÔÓÃ;£¬²¢²»Ö¼ÔÚת´ï¹ØÓÚÓÐЧÐÔ»òÄþ¾²ÐԵĽáÂÛ¡£ÎÞ·¨°ü¹Ü´ËÀàÊÔÑéÐÔÒ©ÎォÀÖ³ÉÍê³ÉÁÙ´²¿ª·¢»ò»ñµÃÎÀÉúÖ÷¹Ü²¿·ÖÅú×¼¡£
ýÌåÁªÏµÈË£º ²³½¡¹«Ë¾ Ashleigh Koss +1-908-205-2572 public.affairs@biogen.com
Ͷ×ÊÕßÁªÏµÈË£º ²³½¡¹«Ë¾ Mike Hencke +1-781-464-2442 IR@biogen.com
[±àÕß×¢]
1.¹ØÓÚLecanemab£¨BAN2401£©
LecanemabÊÇÒ»ÖÖÄâÓÃÓÚÖÎÁư¢¶û´Äº£Ä¬²¡£¨AD£©µÄÊÔÑéÐÔÈËÔ´»¯µ¥¿Ë¡¿¹Ì壬ÊÇng28ÄϹ¬ºÍBioArcticÏàÖúÑз¢½á¹û¡£Lecanemab¿ÉÑ¡ÔñÐÔ½áºÏÖкͲ¢Ïû³ý¿ÉÈÜÐÔ¡¢¶¾ÐԦ£¨A¦Â£©µí·ÛÑùÂѰ׾ۼ¯Ì壨ÔÏËά£©£¬ÕâЩ¾Û¼¯Ìå±»ÈÏΪ¼ÓËÙÁËADµÄÉñ¾ÏµÍ³±äÐÔ½ø³Ì¡£Òò´Ë£¬Lecanemab¿ÉÄܶԼ²²¡²¡Àí»úÖÆ±¬·¢Ó°Ïì²¢ÑÓ»º¼²²¡½øÕ¹¡£¾ÍÖÎÁÆ18¸öÔÂʱԤÏÈÖ¸¶¨µÄÆÊÎö½á¹û¶øÑÔ£¬Ñо¿201±êÃ÷£¬ÔçÆÚADÊÜÊÔÕßµÄÄÔA¦ÂÐî»ý¼õÉÙ£¨P<0.0001£©£¬ADCOMS*²âµÃµÄ¼²²¡½øÕ¹¼õ»º£¨P<0.05£©¡£¸ÃÑо¿ÔÚÖÎÁÆ12¸öÔÂʱδµÖ´ïÖ÷Òª½á¾ÖÖ¸±ê**¡£ÔÚ½¹µã½×¶ÎºÍΪÆÚ9-59¸öÔµÄÐÝÒ©ÆÚ£¨Æ½¾ù24¸öÔ£¬Èë×é½¹µãÑо¿µÄÊÜÊÔÕßΪn=180Àý£©ºóÆô¶¯201Ñо¿µÄ¿ª·ÅÆÚÑÓÐøÊÔÑ飬ÒÔÆÀ¼ÛÄþ¾²ÐÔºÍÓÐЧÐÔ£¬¸Ã½×¶ÎĿǰÕýÔÚ½øÐÐÖС£
2007Äê12ÔÂng28ÄϹ¬ÓëBioArcticÇ©¶©ÁËÐÒ飬»ñµÃÁËLecanemabÓÃÓÚÖÎÁÆADµÄÈ«ÇòÑо¿¡¢¿ª·¢¡¢Éú²úºÍÉÏÊÐȨÀû2014Äê3Ô£¬ng28ÄϹ¬ºÍ²³½¡Ç©¶©ÁËLecanemabµÄÁªºÏ¿ª·¢ºÍÉÌÒµ»¯ÐÒ飬˫·½ÓÚ2017Äê10ÔÂÐÞ¶©Á˸ÃÐÒ顣Ŀǰ£¬Æ¾¾ÝIIÆÚÁÙ´²Ñо¿£¨Ñо¿201£©µÄ½á¹û£¬ÕýÔÚ½øÐÐÖ¢×´ÐÔÔçÆÚADµÄLecanemabÒªº¦ÐÔIIIÆÚÁÙ´²Ñо¿£¨Clarity-AD£©2020Äê7Ô£¬Õë¶ÔÁÙ´²Ç°AD¸öÌ壨ÕâЩ»¼ÕßÁÙ´²ÌåÏÖÕý³££¬µ«´óÄÔÖеí·ÛÑùÂѰ×ˮƽΪÖеȻòÆ«¸ß£©Æô¶¯ÁËIIIÆÚÁÙ´²Ñо¿£¨AHEAD 3-45£©¡£ÒÔÃÀ¹ú¹úÁ¢ÎÀÉúÑо¿Ôº·Ö²¿¹úÁ¢ÀÏÁ仯Ñо¿Ëù×ÊÖúµÄ°¢¶û´Äº£Ä¬ÁÙ´²ÊÔÑéÁªÃË£¨¸ÃÁªÃËΪÃÀ¹ú°¢¶û´Äº£Ä¬²¡ºÍÏà¹Ø³Õ´ôÖ¢µÄѧÊõÁÙ´²ÊÔÑéÌṩ»ù´¡ÉèÊ©£©ºÍng28ÄϹ¬Óë²³½¡Ö®¼äµÄ¹«Ë½ÏàÖúģʽ½øÐÐAHEAD 3-45Ñо¿¡£
*ÓÉng28ÄϹ¬¿ª·¢µÄADCOMS£¨AD×ÛºÏÆÀ·Ö£©½áºÏÁËADAS-Cog£¨°¢¶û´Äº£Ä¬²¡ÆÀ¹ÀÁ¿±í-ÈÏÖª·ÖÁ¿±í£©¡¢CDR£¨ÁÙ´²³Õ´ôÆÀ¶¨Á¿±í£©ºÍMMSE£¨¼òÒ×¾«Éñ״̬¼ì²é±í£©Á¿±íµÄÏîÄ¿£¬ÒÔ±ãÁéÃôµØ¼ì²âÔçÆÚADÖ¢×´µÄÁÙ´²¹¦Ð§±ä¸ïºÍÓ°Ïó±ä¸ï¡£ADCOMSÁ¿±íÆÀ·Ö¹æÄ£Îª0.00ÖÁ1.97£¬ÆÀ·ÖÔ½¸ßÌåÏÖÊÜËðÔ½ÑÏÖØ¡£
**Óëο½å¼ÁÏà±È£¬ADCOMS²âµÃµÄÖÎÁÆ12¸öÔÂʱ×Ô»ùÏßµÄÁÙ´²Ï½µ¼õ»º¡Ý25%µÄÔ¤¼Æ¸ÅÂÊ¡Ý80%¡£
2.ng28ÄϹ¬Óë²³½¡ÔÚ°¢¶û´Äº£Ä¬²¡·½ÃæµÄÏàÖú
ng28ÄϹ¬ºÍ²³½¡ÔÚADÖÎÁÆÒ©ÎïµÄ¿ª·¢ºÍÉÌÒµ»¯·½Ãæ½øÐÐÁËÏàÖú¡£ng28ÄϹ¬ÊÇLecanemabÁªºÏ¿ª·¢µÄǣͷÈË¡£
3.ng28ÄϹ¬ÓëBioArcticÔÚ°¢¶û´Äº£Ä¬²¡·½ÃæµÄÏàÖú
×Ô2005ÄêÒÔÀ´£¬BioArcticÓëng28ÄϹ¬¾ÍADÖÎÁÆÒ©ÎïµÄ¿ª·¢ºÍÉÌÒµ»¯½øÐÐÁ˺ã¾ÃÏàÖú¡£2007Äê12ÔÂÇ©ÊðÁËLecanemab¿¹ÌåµÄÉÌÒµ»¯ÐÒ飬2015Äê5ÔÂÇ©ÊðÁËAD¿¹ÌåLecanemab±¸·ÝµÄ¿ª·¢ºÍÉÌÒµ»¯ÐÒé¡£ng28ÄϹ¬ÂôÁ¦AD²úÆ·µÄÁÙ´²¿ª·¢¡¢ÉÏÊÐÉêÇëºÍÉÌÒµ»¯¡£BioArctic²»µ£¸ºÓÃÓÚADµÄLecanemabµÄ¿ª·¢±¾Ç®¡£
4.¹ØÓÚng28ÄϹ¬Öêʽ»áÉç
ng28ÄϹ¬Öêʽ»áÉçÊÇÒ»¼Ò×ܲ¿Î»ÓÚÈÕ±¾µÄÁìÏÈÈ«ÇòÖÆÒ©¹«Ë¾¡£ng28ÄϹ¬Öêʽ»áÉçµÄÆóÒµÀíÄî»ùÓÚÌåÌùÈËÀཡ¿µ£¨hhc£©ÀíÄ¼´½«»¼Õß¼°¼ÒÊôµÄÀûÒæ·ÅÔÚÊ×λ£¬ÎªÌáÉýÆä¸£ìí×ö³öТ¾´¡£¹«Ë¾Æ¾½èÑз¢»ú¹¹¡¢Éú²ú»ùµØºÍÓªÏú×Ó¹«Ë¾µÄÈ«ÇòÍøÂ磬ÖÂÁ¦ÓÚͨ¹ýÕë¶ÔÒ½ÁÆÐèÇóδ»ñµÃ³ä·ÖÂú×ãµÄ°Ð²¡ÔîÌṩÁ¢Òì²úÆ·£¬ÓÈÆäÆ«ÖØÓÚÉñ¾Ñ§ºÍÖ×ÁöѧսÂÔÁìÓò£¬ÊµÏÖ¹«Ë¾µÄÌåÌùÈËÀཡ¿µÀíÄî¡£
ng28ÄϹ¬¼Æ»®ÀûÓôӰ¢¶û´Äº£Ä¬²¡ÖÎÁÆÒ©ÎïÑз¢ºÍÉÏÊÐÖлñµÃµÄ¾Ñ飬½¨Á¢¡°ng28ÄϹ¬³Õ´ôƽ̨¡±¡£ng28ÄϹ¬¼Æ»®Í¨¹ý¸Ãƽ̨¹¹½¨¡°³Õ´ôÉú̬ϵͳ¡±£¬ÓëÒ½ÁÆ»ú¹¹¡¢Õï¶Ï¿ª·¢¹«Ë¾¡¢Ñо¿×éÖ¯ºÍÉúÎïΣº¦Í¶×ʹ«Ë¾µÈÏàÖúͬ°éÒÔ¼°Ë½È˰ü¹Ü»ú¹¹¡¢½ðÈÚÒµ¡¢½¡Éí¾ãÀÖ²¿¡¢Æû³µÖÆÔìÉÌ¡¢ÁãÊÛÉ̺ͻ¤Àí»ú¹¹µÈÏàÖúͬ°éÏàÖú£¬Îª³Õ´ô»¼Õß¼°Æä¼ÒÍ¥´øÀ´Ðµĸ£ìí¡£ÓûÁ˽â¸ü¶à¹ØÓÚng28ÄϹ¬Öêʽ»áÉçµÄÐÅÏ¢£¬Çë»á¼ûhttps://www.eisai.com¡£
5.¹ØÓÚng28ÄϹ¬
ÔÚng28ÄϹ¬£¬ÌåÌùÈËÀཡ¿µ£¨hhc£©ÊÇÎÒÃǵÄÄ¿±ê¡£ÎÒÃǽ«»¼Õß¼°¼ÒÊôµÄÀûÒæ·ÅÔÚÊ×λ£¬ÎªÌáÉýÆä¸£ìí×ö³öТ¾´¡£×÷Ϊ×ܲ¿Î»ÓÚ¶«¾©µÄng28ÄϹ¬Öêʽ»áÉçµÄÃÀ¹úÒ©Òµ×Ó¹«Ë¾£¬ÎÒÃÇÈȰ®»¼Õß»¤Àí£¬ÕâÇýʹÎÒÃÇŬÁ¦·¢Ã÷ºÍ¿ª·¢Á¢ÒìÁÆ·¨ÒÔ×ÊÖú½â¾öδÂú×ãµÄÒ½ÁÆÐèÇó¡£ng28ÄϹ¬ÊÇÒ»¼ÒÈ«ÃæÕûºÏµÄÖÆÒ©ÆóÒµ£¬ÒµÎñÉæ¼°Ö×ÁöѧºÍÉñ¾²¡Ñ§£¨³Õ´ôÏà¹Ø¼²²¡ºÍÉñ¾ÍËÐÐÐÔ¼²²¡£©ÕâÁ½´óÈ«ÇòÒµÎñ°å¿é¡£ÎÒÃǵÄÃÀ¹ú×ܲ¿¡¢ÉÌÒµºÍÁÙ´²¿ª·¢×é֯λÓÚÐÂÔóÎ÷ÖÝ£»Ì½Ë÷ʵÑéÊÒλÓÚÂíÈøÖîÈûÖݺͱöϦ·¨ÄáÑÇÖÝ£»È«ÇòÐèÇóÁ´×é֯λÓÚÂíÀïÀ¼Öݺͱ±¿¨ÂÞÀ´ÄÉÖÝ¡£ÓûÁ˽â¸ü¶à¹ØÓÚng28ÄϹ¬µÄÐÅÏ¢£¬Çë»á¼ûwww.eisai.com/US £¬²¢¹Ø×¢ÎÒÃǵÄTwitterºÍLinkedInÕ˺š£
6.¹ØÓÚ²³½¡
×÷ΪÉñ¾¿ÆÑ§µÄÏȷ棬²³½¡ÎªÈ«Çòî¾»¼ÑÏÖØÉñ¾¼²²¡µÄ»¼Õß̽Ѱ¡¢Ñз¢ºÍÌṩÁ¢ÒìÁÆ·¨¡£²³½¡ÊÇCharles Weissmann¡¢Heinz Schaller¡¢Sir Kenneth MurrayÓëŵ±´¶û½±»ñµÃÕßWalter GilbertºÍPhillip SharpЯÊÖÔÚ1978Ä꽨Á¢µÄÈ«ÇòÊ×ÅúÉúÎï¿Æ¼¼¹«Ë¾Ö®Ò»¡£Èç½ñ£¬²³½¡ÓµÓÐÖÎÁƶ෢ÐÔÓ²»¯Ö¢µÄÁìÏÈÒ©Îï×éºÏ£¬ÍƳöÁËÊ׸ö»ñÅúÓÃÓÚÖÎÁƼ¹ËèÐÔ¼¡Î®ËõÖ¢µÄÒ©Î²¢ÕýÔÚÌṩÊ׸öÒ²ÊÇΨһ»ñÅú½â¾ö°¢¶û´Äº£Ä¬²¡µÄÃ÷È·²¡ÀíѧµÄÖÎÁÆÒªÁì¡£²³½¡»¹ÔÚ½øÐÐÉúÎïÀàËÆÒ©ÉÌÒµ»¯£¬²¢ÖÂÁ¦ÓÚÍÆ½øÉñ¾¿ÆÑ§ÁìÓòÐÐÒµµÄ×î¶àÑù»¯ÇþµÀ£¬Õ⽫¸Ä±ä¾ßÓи߶ÈδÂú×ãµÄÒ½ÁÆÐèÇóµÄÈô¸ÉÁìÓò»¼Õߵıê×¼ÖÎÁÆ¡£
2020Ä꣬²³½¡ÌᳫÁËÒ»ÏîΪÆÚ20Äê¡¢ºÄ×Ê2.5ÒÚÃÀÔªµÄ´óµ¨½¨Ò飬ּÔÚ½â¾öÆøºò¡¢½¡¿µºÍ¹«ÕýµÈÃÜÇÐÏà¹ØµÄÎÊÌâ¡£Healthy Climate, Healthy Lives?Ö¼ÔÚÏû³ý¹«Ë¾ÔËÓªÖеĻ¯Ê¯È¼ÁÏ£¬²¢ÓëÖªÃû»ú¹¹½¨Á¢ÏàÖú¹ØÏµ£¬ÒÔÍÆ½ø¿ÆÑ§½ø²½¡¢¸ÄÉÆÈËÀཡ¿µ½á¹û£¬²¢ÎªÒ½ÁÆË®Æ½µÍϵÄÉçÇøÌṩ֧³Ö¡£
¸Ã¹«Ë¾¾³£ÔÚÆäÍøÕ¾www.biogen.comÉÏÐû²¼¶ÔͶ×ÊÕß¶øÑÔ¿ÉÄܺÜÖØÒªµÄÐÅÏ¢¡£ÓûÁ˽â¸ü¶àÐÅÏ¢£¬Çë»á¼ûwww.biogen.com£¬²¢ÔÚÉ罻ýÌå–Twitter¡¢LinkedIn¡¢Facebook¡¢YouTubeÉϹØ×¢²³½¡µÄÕ˺š£
7.²³½¡Äþ¾²¸Û
±¾ÐÂΟåÖаüÀ¨Ç°Õ°ÐÔÉùÃ÷£¬°üÀ¨Æ¾¾Ý1995ÄêÃÀ¹ú¡¶Ë½ÈË֤ȯËßËϸïз¨°¸¡·ÖеÄÄþ¾²¸ÛÌõ¿î¾ÍLecanemabµÄDZÔÚÁÙ´²ÁÆÐ§£»LecanemabºÍADUHELMµÄDZÔÚ»ñÒæ¡¢Äþ¾²ÐÔºÍÓÐЧÐÔ£»Ç±ÔÚ¼à¹ÜÌÖÂÛ¡¢Ìá½»ºÍÅú×¼¼°Æäʱ¼ä°²ÅÅ£»Clarity ADÑо¿µÄÔ¤ÆÚÊý¾Ý½â¶Á£»°¢¶û´Äº£Ä¬²¡µÄÖÎÁÆ£»²³½¡Óëng28ÄϹ¬ÏàÖúµÄÔ¤ÆÚÐ§ÒæºÍDZÁ¦£»²³½¡µÄÉÌÒµÒµÎñºÍÑз¢ÏîÄ¿µÄDZÁ¦£¬°üÀ¨LecanemabºÍADUHELM£»ÒÔ¼°ÓëÒ©Î↑·¢ºÍÉÌÒµ»¯Ïà¹ØµÄΣº¦ºÍ²»È·¶¨ÐÔ·½Ãæ×÷³öµÄ³ÂÊö¡£¿Éͨ¹ý¡°Ä¿±ê¡±¡¢¡°Ô¤ÆÚ¡±¡¢¡°ÏàÐÅ¡±¡¢¡°¿ÉÒÔ¡±¡¢¡°Ô¤¼Æ¡±¡¢¡°ÆÚ´ý¡±¡¢¡°Ô¤²â¡±¡¢¡°¼Æ»®¡±¡¢¡°»òÐí¡±¡¢¡°¼Æ»®¡±¡¢ ¡°Ç±ÔÚ¡±¡¢¡°¿ÉÄÜ¡±¡¢ ¡°½«Òª¡±µÈ´ÊÓï»òÆäËû¾ßÓÐÏàËÆ¼ÄÒåµÄ´ÊÓïºÍÊõÓïÀ´Ê¶±ðÕâЩǰհÐÔ³ÂÊö¡£Ò©Î↑·¢ºÍÉÌÒµ»¯Éæ¼°¸ßΣº¦£¬Ö»ÓÐÉÙÊýÑз¢ÏîÄ¿×îÖÕ»áÀÖ³ÉʵÏÖ²úÆ·µÄÉÌÒµ»¯¡£ÔçÆÚÁÙ´²ÊÔÑéµÄ½á¹û¿ÉÄÜÎÞ·¨´ú±íºóÆÚ»ò¸ü´ó¹æÄ£ÁÙ´²ÊÔÑéµÄÍêÕû½á¹û»ò¸÷Ïî½á¹û£¬Ò²²»¿ÉÈ·±£Ò©Îï»á»ñµÃ¼à¹Ü²¿·ÖµÄÅú×¼¡£Äú²»Ó¦Ì«¹ýÒÀÀÃ÷ÈÕâЩ³ÂÊö»òËùÐû²¼µÄ¿ÆÑ§Êý¾Ý¡£
ÕâЩÉùÃ÷Éæ¼°¿ÉÄܵ¼ÖÂʵ¼Ê½á¹ûÓë´ËÀàÉùÃ÷Öз´Ó¦µÄ½á¹û±£´æÊµÖÊÐÔ²î±ðµÄΣº¦ºÍ²»È·¶¨ÐÔ£¬°üÀ¨µ«²»ÏÞÓÚÁÙ´²ÊÔÑéÆÚ¼ä»ñµÃµÄÌØ±ðÊý¾Ý¡¢ÆÊÎö»ò½á¹û¿ÉÄܱ¬·¢µÄ·ÇÔ¤ÆÚÎÊÌ⣻²»Á¼Äþ¾²ÐÔʼþµÄ±¬·¢£»·ÇÔ¤ÆÚ±¾Ç®»òÑÓ³ÙµÄΣº¦£»ÆäËû·ÇÔ¤ÆÚÕϰµÄΣº¦£»Ïò¼à¹Ü»ú¹¹Ìá½»µÄʱ¼ä¿ÉÄܱÈÔ¤ÆÚ¸ü³¤»ò¸üÄÑÍê³É£»¼à¹Ü»ú¹¹¿ÉÄÜÐèÒªÌØ±ðÐÅÏ¢»ò½øÒ»²½Ñо¿£¬»ò¿ÉÄÜʧ°Ü»ò¾Ü¾øÅú×¼»ò¿ÉÄÜÑÓ³Ù²³½¡ºòѡҩÎ°üÀ¨Lecanemab£©µÄÅú×¼£»Ïò¼à¹Ü»ú¹¹Ìá½»µÄʵ¼Êʱ¼äºÍÄÚÈÝÒÔ¼°¼à¹Ü»ú¹¹×ö³ö¹ØÓÚLecanemabµÄ¾ö¶¨£»Lecanemab¿ª·¢ÀֳɺÍDZÔÚÉÌÒµ»¯µÄ²»È·¶¨ÐÔ£»Î´Äܱ£»¤ºÍÖ´Ðв³½¡µÄÊý¾Ý¡¢ÖªÊ¶²úȨºÍÆäËûרÓÐȨÒÔ¼°Óë֪ʶ²úȨË÷ÅâºÍÒìÒéÏà¹ØµÄ²»È·¶¨ÐÔ£»²úÆ·ÔðÈÎË÷Å⣻µÚÈý·½ÏàÖúΣº¦£»ÒÔ¼°Á¬Ðø±£´æµÄCOVID-19ÒßÇé¶Ô²³½¡ÒµÎñ¡¢ÔËÓª½á¹ûºÍ²ÆÎñ×´¿öµÄÖ±½ÓºÍ¼ä½ÓÓ°Ïì¡£ÉÏÊöǰհÐÔÉùÃ÷ÁгöÁËÐí¶à¿ÉÄܵ¼ÖÂʵ¼Ê½á¹ûÓë²³½¡ÔÚÈκÎǰհÐÔÉùÃ÷ÖÐÔ¤ÆÚµÄ½á¹û²î±ðµÄÒòËØ£¬µ«²¢Î´ÁýÕÖÈ«²¿µÄ¿ÉÄÜÒòËØ¡£Í¶×ÊÕßÓ¦¿¼ÂÇÕâÒ»¾¯Ê¾ÐÔÉùÃ÷£¬ÒÔ¼°²³½¡×î½üµÄÄê¶È»ò¼¾¶È±¨¸æÒÔ¼°°Ù½¡ÏòÃÀ¹ú֤ȯ½»Ò×ίԱ»áÌá½»µÄÆäËû±¨¸æÖÐÈ·¶¨µÄΣº¦ÒòËØ¡£ÕâЩǰհÐÔÉùÃ÷»ùÓÚ²³½¡Ä¿Ç°µÄÐÅÄîºÍÔ¤ÆÚ£¬½öÔÚ±¾ÐÂΟåÐû²¼Ö®ÈÕÐû²¼¡£²³½¡ÎÞÈκÎÒåÎñ¹ûÕæ¸üÐÂÈκÎǰհÐÔÉùÃ÷£¬ÎÞÂ۸õȸüÐÂÊÇ»ùÓÚÐÂÐÅÏ¢¡¢Î´À´¿ª·¢£¬»òÕßÈÎºÎÆäËûÔÒò¡£